SCHEMBL160792

SCHEMBL160792

[c]1[c]c2ccccc2cc1-c1ccc2ccccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
ALOX5 P09917 1/20 0.41
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
CYP1A2 P05177 4/20 0.38
CYP11B1 P15538 3/20 0.38
CYP11B2 P19099 3/20 0.38
CYP17A1 P05093 1/20 0.38
CYP19A1 P11511 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 1/20 0.37
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 3/20 0.36
NPC1 O15118 2/20 0.36
MAPT P10636 2/20 0.36
RAB9A P51151 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4248295 0.82 KMT2A (0.34) SMN1; SMN2ALDH1A1KDM4ENPC1MAPT
SCHEMBL9634340 0.79 ESR1 (0.46) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL1719526 0.74 GSTP1 (0.44) GSTP1ESR1ESR2ALOX5HSD17B1
SCHEMBL291173 0.73 GSTP1 (0.42) GSTP1ESR1ESR2ALOX5HSD17B1
SCHEMBL2267372 0.72 GSTP1 (0.45) GSTP1ESR1ESR2ALOX5HSD17B1
SCHEMBL3089094 0.71 HSD17B1 (0.50) GSTP1ESR1ESR2ALOX5HSD17B1
SCHEMBL239121 0.71 ESR1 (0.71) GSTP1ESR1ESR2ALOX5HSD17B1
SCHEMBL15902840 0.71 ESR1 (0.71) GSTP1ESR1ESR2ALOX5HSD17B1
SCHEMBL30239993 0.71 ESR1 (0.71) GSTP1ESR1ESR2ALOX5HSD17B1
SCHEMBL5013872 0.71 ESR1 (0.71) GSTP1ESR1ESR2ALOX5HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9328079-B2 Process for producing optically active amine TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-05-03 US claimed
US-9255049-B2 Ruthenium complex and method for preparing optically active alcohol compounds using the same as a catalyst TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-02-09 US claimed
US-20150210657-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINE TAKASAGO INTERNATIONAL CORPORATION (JP) 2015-07-30 US claimed
US-9079931-B2 Ruthenium complex and method for preparing optically active alcohol compound TAKASAGO INTERNATIONAL CORPORATION (JP) 2015-07-14 US claimed
EP-2563799-B1 RUTHENIUM COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE ALCOHOL COMPOUND TAKASAGO PERFUMERY CO LTD (JP) 2015-02-11 EP claimed
US-20140187809-A1 NOVEL RUTHENIUM COMPLEX AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND USING SAME AS CATALYST TAKASAGO INTERNATIONAL CORPORATION (JP) 2014-07-03 US claimed
EP-2695887-A1 NOVEL RUTHENIUM COMPLEX AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND USING SAME AS CATALYST Takasago International Corporation (JP) 2014-02-12 EP claimed
EP-2563799-A1 RUTHENIUM COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE ALCOHOL COMPOUND Takasago International Corporation (JP) 2013-03-06 EP claimed
US-20130041151-A1 RUTHENIUM COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE ALCOHOL COMPOUND TAKASAGO INTERNATIONAL CORPORATION (JP) 2013-02-14 US claimed
WO-2011135753-A1 RUTHENIUM COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE ALCOHOL COMPOUND TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-11-03 WO claimed
US-7642357-B2 Iridium complexes TAKASAGO INTERNATIONAL CORPORATION (JP) 2010-01-05 US claimed
US-20090036696-A1 IRIDIUM COMPLEXES TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-02-05 US claimed
US-20240158424-A1 METHOD FOR PRODUCING DIPHOSPHINE MONOXIDE TAKASAGO INTERNATIONAL CORPORATION (JP) 2024-05-16 US disclosed
EP-4361162-A2 METHOD FOR PRODUCING DIPHOSPHINE MONOXIDE Takasago International Corporation (JP) 2024-05-01 EP disclosed
US-11185851-B2 Polymer-supported metal TAKASAGO INTERNATIONAL CORPORATION (JP) 2021-11-30 US disclosed
EP-3417939-A1 METAL-SUPPORTED MACROMOLECULE Takasago International Corporation (JP) 2018-12-26 EP disclosed
WO-2004074255-A2 METHOD FOR PRODUCING AN OPTICALLY ACTIVE TETRAHYDROQUINOLINE TAKASAGO INTERNATIONAL CORPORATION (JP) 2004-09-02 WO disclosed
US-20040170866-A1 Cyclic tertiary amine compound and organic electroluminescent device containing the compound GUOFANG WANG (JP) 2004-09-02 US disclosed
US-6761981-B2 HIGH EFFICIENCY AND LONG SERVICE LIFE; MARCROCYCLIC RINGS COMPRISING TERTIARY AMINES CONTAINED IN A HOLE TRANSPORT LAYER AND/OR LUMINESCENT LAYER OF AN ELECTROLUMINESCENT DEVICE SUCH AS FLAT SCREEN DISPLAY CHISSO CORPORATION (JP) 2004-07-13 US disclosed
US-20020058155-A1 Cyclic tertiary amine compound and organic electroluminescent device containing the compound CHISSO CORPORATION (JP) 2002-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240158424-A1 METHOD FOR PRODUCING DIPHOSPHINE MONOXIDE TDO2, SCO2, DUOX1 GSTP1 168/4885ESR1 4231/4885ESR2 3413/4885
US-20090036696-A1 IRIDIUM COMPLEXES HAX1, MLX, H1-0 GSTP1 3552/4885ESR1 1427/4885ESR2 841/4885
US-20020058155-A1 Cyclic tertiary amine compound and organic electroluminescent device containing the compound AOC2, AOC3, CCNL2 GSTP1 4688/4885ESR1 604/4885ESR2 987/4885
US-20130041151-A1 RUTHENIUM COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE ALCOHOL COMPOUND ADH5, ADH1C, ADH1A GSTP1 1127/4885ESR1 1798/4885ESR2 1322/4885
US-20140187809-A1 NOVEL RUTHENIUM COMPLEX AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND USING SAME AS CATALYST ADH1C, ADH5, ADH1A GSTP1 1567/4885ESR1 2388/4885ESR2 1839/4885
US-20150210657-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINE HRH3, HRH1, ATIC GSTP1 4137/4885ESR1 2301/4885ESR2 1936/4885
US-20040170866-A1 Cyclic tertiary amine compound and organic electroluminescent device containing the compound AOC2, AOC3, CCNL2 GSTP1 4688/4885ESR1 604/4885ESR2 987/4885
US-11185851-B2 Polymer-supported metal SOD1, PCNA, MAX GSTP1 2385/4885ESR1 3813/4885ESR2 4147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.